NEW YORK, Oct. 22 (GenomeWeb News) - Affymetrix reported revenues of $76.2 million for the third quarter today, up from $ 72.7 million for the same period last year.

These revenues included $71.1 million in product revenue, compared to $62.9 million for the third quarter of 2002.

The company’s net income rose with revenues, to $5.8 million for the quarter, compared to $0.6 million for the same period last year. This is the third consecutive quarter of profitability for the Santa Clara, Calif. microarray company.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.